Lin Yi - Mayo Clin, Div Hematol, Rochester, MN USA

基本信息

浏览量：232

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 564 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Racial and ethnic differences in clinical outcomes among multiple myeloma patients treated with CAR T-cell therapy

Lauren C Peres, Laura B Oswald, Christen M Dillard, Gabriel De Avila, Taiga Nishihori,Brandon J Blue,Ciara L Freeman, Frederick L Locke,Melissa Alsina,Omar A Castaneda Puglianini, Leyla Shune,Douglas W Sborov,

Blood advances (2023)

引用0浏览0WOS引用

Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival

Charalampos Charalampous,Utkarsh Goel,Prashant Kapoor,Moritz Binder, Francis K. Buadi,David Dingli,Angela Dispenzieri, Amie L. Fonder,Morie A. Gertz,Wilson Gonsalves, Suzanne R. Hayman,Miriam A. Hobbs,

Clinical Lymphoma Myeloma and Leukemiano. 3 (2023): 413-420

引用0浏览0WOS引用

P-003 Clinical outcomes among multiple myeloma and lymphoma patients taking beta-blockers undergoing CAR-T therapy

Kristina Balandan,Yi Hwa,Radhika Bansal,Arushi Khurana,Patrick Johnston,Stephen Ansell,Nora Bennani,Moritz Binder,David Dingli,Morie Gertz, Suzanne Haymann,Prashant Kapoor,

Clinical Lymphoma Myeloma and Leukemia (2023)

引用0浏览0引用

Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM)

Doris K. Hansen,Krina K. Patel,Lauren C. Peres,Mehmet H. Kocoglu, Leyla Shune, Gary Simmons, Christopher J. Ferreri,Shebli Atrash,Ricardo Daniel Parrondo,Saurabh Chhabra, Patrick Costello, Shonali Midha,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Prognostic Value of Month 1 Bone Marrow and PET MRD Status in CAR-T Therapy for Myeloma

Radhika Bansal,Sikander Ailawadhi,Jeremy T Larsen,Morie Gertz, Mr. Matthew Hathcock,David Dingli,Prashant Kapoor,Taxiarchis Kourelis, Suzanne R Hayman,Rahma Warsame,Moritz Binder,Ricardo Daniel Parrondo,

Transplantation and Cellular Therapy（2023）

引用0浏览0引用

Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

Charles Gaulin, Matthew L. Ulrickson,Muhammad Husnain,Madiha Iqbal,Paschalis Vergidis,Allison Rosenthal,Hemant Murthy,Carolyn Mead-Harvey,Yucai Wang,Januario E. Castro, Jeanne Palmer, Jose F. Leis,

Transplantation and Cellular Therapyno. 2 (2023)

引用0浏览0引用

Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy

Evandro D Bezerra,Madiha Iqbal,Javier Munoz,Arushi Khurana,Yucai Wang,Matthew J Maurer,Radhika Bansal,Matthew A Hathcock,Nora Bennani,Hemant S Murthy,Allison C Rosenthal,Jonas Paludo,

Blood Adv（2023）

引用0浏览0WOS引用

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma

Julia E. Wiedmeier-Nutor,Madiha Iqbal,Allison C. Rosenthal,Evandro D. Bezerra,Juan Esteban Garcia-Robledo,Radhika Bansal,Patrick B. Johnston, Matthew Hathcock,Jeremy T. Larsen,P. Leif Bergsagel,Yucai Wang,Craig B. Reeder,

Clinical Lymphoma Myeloma and Leukemiano. 6 (2023): 456-462

引用0浏览0引用

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

Sattva S. Neelapu,Caron A. Jacobson,Armin Ghobadi,David B. Miklos,Lazaros J. Lekakis,Olalekan O. Oluwole,Yi Lin, Ira Braunschweig,Brian T. Hill, John M. Timmerman,Abhinav Deol, Patrick M. Reagan,

Blood（2023）

引用0浏览0引用

Efficacy Outcomes and Characteristics of Patients With Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity After Treatment With Ciltacabtagene Autoleucel (cilta-cel) in CARTITUDE-1

Nikhil Munshi, Bruno Pavia,Thomas Martin,Saad Usmani,Yi Lin, Jordan Schecter,Carolyn Jackson,Deepu Madduri,Enrique Zudaire, Tzu-Min Yeh, J. Blake Bartlett, Lida Pacaud,

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S487-S488

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn